已收盤 11-06 16:00:00 美东时间
+0.308
+1.57%
SRX Global announced the activation of UC Davis as a clinical trial site for the Phase 1 CERTAIN-T study evaluating CER-1236 in hematologic malignancies. UC Davis also serves as the primary manufacturing site for CER-1236, expected to enhance patient recruitment and streamline treatment logistics. This milestone follows SRX's definitive agreement to acquire CERo Therapeutics. The activation strengthens CERo's clinical trial capabilities and suppo...
10-26 13:05
Rareview Tax Advantaged Income ETF (RTAI) declares $0.0895 monthly dividend. Payable Oct. 5; for shareholders of record Oct. 2; ex-div Oct. 2. See RTAI Dividend Scorecard, Yield Chart, & Dividend Grow...
10-02 18:19
SRTS 2026财年第二季度业绩电话会议:由于8台SRT-100设备顺延至第三季度,营收降至230万美元,而管理层预计下半年表现将更加强劲。
08-14 08:41
Rareview Tax Advantaged Income ETF (RTAI) declares $0.0825/share monthly dividend. Payable July 6; for shareholders of record July 2; ex-div July 2. See RTAI Dividend Scorecard, Yield Chart, & Dividen...
07-02 16:41